RC(300596) 新浪财经·2025-04-24 02:44Group 1 - The company reported a revenue of 5.687 billion yuan for 2024, representing a year-on-year growth of 7.74%, and a net profit attributable to shareholders of 426 million yuan, up 17.61% year-on-year [1] - In Q4 2024, the company achieved a revenue of 1.422 billion yuan, showing slight growth year-on-year, and a net profit of 112 million yuan, which is a 41.32% increase year-on-year and a 19.75% increase quarter-on-quarter [1] - The company adjusted its global marketing strategy in 2024, overcoming economic downturns and changes in the international business environment, while maintaining strategic focus and flexibility in marketing [1] Group 2 - The company is a high-tech enterprise with independent research and continuous innovation capabilities, focusing on sustainable development in chemistry and biotechnology [2] - The company has three main business lines: high polymer materials for anti-aging, lubricant additives, and life sciences, which contribute to its diversified business strategy [2] - The company introduced Korean electronic-grade polyimide (PI) material technology in 2024, filling a gap in domestic electronic-grade PI materials [2] Group 3 - The company maintains a "strongly recommended" investment rating, with projected revenues of 6.113 billion yuan, 6.603 billion yuan, and 7.593 billion yuan for 2025-2027, and net profits of 495 million yuan, 505 million yuan, and 636 million yuan respectively [2] - The expected EPS for 2025-2027 is 2.16 yuan, 2.20 yuan, and 2.77 yuan, with corresponding PE ratios of 12.9, 12.6, and 10.0 [2]